Rhodes John B 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed May 8, 2019
Insider Transaction Report
Form 4
Rhodes John B
Director
Transactions
- Award
Stock Option
2019-05-06+45,000→ 45,000 totalExercise: $2.05From: 2020-05-06Exp: 2029-05-06→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan.